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Background: The peripheral immune system is implicated in modulating microglial activation, neurodegeneration
and disease progression in amyotrophic lateral sclerosis (ALS). Specifically, there is reduced thymic function and
regulatory T cell (Treg) number in ALS patients and mutant superoxide dismutase 1 (SOD1) mice, while passive
transfer of Tregs ameliorates disease in mutant SOD1 mice. Here, we assessed the effects of augmenting
endogenous CD4+ T cell number by stimulating the thymus using surgical castration on the phenotype of
transgenic SOD1G93A mice.
Method: Male SOD1G93A mice were castrated or sham operated, and weight loss, disease onset and progression
were examined. Thymus atrophy and blood CD4+, CD8+ and CD4+ FoxP3+ T cell numbers were determined by
fluorescence activated cell sorting (FACS). Motor neuron counts, glial cell activation and androgen receptor (AR)
expression in the spinal cord were investigated using immunohistochemistry and Western blotting. Differences
between castrated and sham mice were analysed using an unpaired t test or one-way ANOVA.
Results: Castration significantly increased thymus weight and total CD4+ T cell numbers in SOD1G93A mice,
although Tregs levels were not affected. Despite this, disease onset and progression were similar in castrated and
sham SOD1G93A mice. Castration did not affect motor neuron loss or astrocytic activation in spinal cords of
SOD1G93A mice; however, microglial activation was reduced, specifically M1 microglia. We also show that AR is
principally expressed in spinal motor neurons and progressively downregulated in spinal cords of SOD1G93A mice
from disease onset which is further enhanced by castration.
Conclusions: These results demonstrate that increasing thymic function and CD4+ T cell number by castration
confers no clinical benefit in mutant SOD1 mice, which may reflect an inability to stimulate neuroprotective Tregs.
Nonetheless, castration decreases M1 microglial activation in the spinal cord without any clinical improvement and
motor neuron rescue, in contrast to other approaches to suppress microglia in mutant SOD1 mice. Lastly,
diminished AR expression in spinal motor neurons, which links to another motor neuron disorder, spinal bulbar
muscular atrophy (SBMA), may contribute to ALS pathogenesis and suggests a common disease pathway in ALS
and SBMA mediated by disruption of AR signalling in motor neurons.
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Neuroinflammation consisting of resident astrocyte and
microglial activation and infiltration of peripheral T cells
into the central nervous system (CNS) occurs in the pro-
gression of amyotrophic lateral sclerosis (ALS), an unre-
lenting and fatal disease caused by selective loss of
motor neurons in the brain, brainstem and spinal cord.
Neuroinflammatory responses in ALS are often referred
to as a double-edged sword, with both beneficial and
deleterious effects on motor neuron survival [1]. Both
the innate and adaptive immune systems play important
roles in neuroinflammatory responses in ALS. In the
CNS, the innate immune response involves activation of
pro-inflammatory M1 or anti-inflammatory M2 microglia
[2-4]. Microglial expression of inducible nitric oxide syn-
thase (iNOS) or arginase 1 (Arg1) is typically used to iden-
tify M1 and M2 microglia, respectively. The adaptive
immune system primarily involves the action of T cells
which differ in expression of cell surface molecules and
functional roles. T cells include CD8+ cytotoxic T cells
which induce apoptosis of target cells and CD4+ T helper
cells which suppress the effects of CD8+ T cells and M1
microglia [5]. Importantly, T cells born in the bone mar-
row must first migrate to the thymus where they undergo
maturation to CD4+ and/or CD8+ cells [6].
T cell infiltration is widely observed in the spinal cord
and cerebral cortex of ALS patients [7-11]. CD4+ T cells
are recruited to sites of motor neuron degeneration such
as the spinal cord ventral horns and corticospinal tracts
[12]. Studies in transgenic mice expressing mutant
superoxide dismutase 1 (SOD1) linked to ALS have
yielded important insights into the role of T cells in ALS
progression. SOD1G93A mice on recombination-activating
gene 2 (RAG2) or CD4 knockout backgrounds, both ablat-
ing functional CD4+ T cells, showed accelerated disease
progression and altered microglial activation [13]. Further-
more, deletion of T cell receptor β chain to prevent T
cell maturation also accelerated disease progression in
SOD1G93A mice [14]. These studies suggest that specific
T cell subtypes may confer protection in ALS models.
Recently, the T cell subtype responsible for neuroprotec-
tion in ALS, CD4+ CD25+ FoxP3+ regulatory T cells
(Tregs), was identified by passive transfer of Tregs into
SOD1G93A mice prolonging lifespan [15,16]. Tregs sup-
press M1 microglia activation and CD8+ T cell and CD4+
CD25− T effector cell expansion which would promote
motor neuron survival [17-19].
The T cell population is maintained by differentiation
and release of mature T cells at the thymus into circula-
tion. The thymus undergoes atrophy and inactivation
with normal ageing which is driven by circulating andro-
gens released from puberty [6]. It was recently shown
that thymus inactivation is significantly accelerated with
reduced CD4+ T cell numbers in the blood of ALSpatients and mutant SOD1 mice [20,21]. In particular,
Treg numbers are reduced in ALS patients which correl-
ate with increased disease severity [21]. These results
suggest that a chronic deficiency of thymic function and
CD4+ T cells occurs in ALS which may potentiate neu-
roinflammation, motor neuron loss and disease progres-
sion. Therefore, strategies that augment thymic function
and CD4+ T cell production may ameliorate ALS pro-
gression. Here, we tested the effects of thymic stimula-
tion on the disease phenotype of SOD1G93A mice using
castration which is well known to both activate the thy-
mus and boost T cell levels.
Methods
Ethics statement
All experiments conformed to the Australian National
Health and Medical Research Council published code of
practice and were approved by the Howard Florey Insti-
tute Animal Ethics Committee (permit number 12–012).
Animals and castration surgery
Transgenic SOD1G93A mice derived from the B6SJL-TgN
(SOD1*G93A)1Gur/J line (Jackson Laboratory, Bar
Harbor, ME) were backcrossed and maintained on a
pure C57BL/6 background. Prepubescent (5-week-old)
male mice were anesthetised via isoflurane using a gas
anaesthetic machine and either castrated (Cx) or sham
operated. A shallow 1-cm incision was made along the
ventral midline of the scrotum. The tunica was exposed,
and a small 5-mm incision was made at the base and the
testis exposed. The spermatic artery and vas deferens
were sutured to prevent bleeding before removing the
testis by cutting below the ligature. After removing both
testes, the scrotum was closed with sutures and Michel
clips (Fine Science Tools, North Vancouver, British
Columbia, Canada). Mice were injected with meloxicam
(3 mg/kg, SC) for analgesia and warmed to recovery
under a heat lamp. Surgical instruments were sterilised
by autoclave prior to surgery. Age-matched and intact
C57BL/6 wild-type (WT) mice were used as controls for
immunoblotting and immunohistochemistry. For andro-
gen receptor (AR) immunoblotting, separate intact WT
and SOD1G93A males aged postnatal day 60 (P60), P90
and P120 were used. Mice were killed by lethal injection
(sodium pentobarbitone, 100 mg/kg, IP).
Behavioural analysis
Mouse weight and locomotor function were analysed
weekly from P60 using an accelerating Mouse Rota-Rod
47600 (Ugo Basile, Monvalle, Italy). Mice were trained at
P60 by one constant speed (16 rpm) over 5 min and two
ramping sessions at 3 to 30 rpm over 5 min with 10-min
rest intervals between each training session. The next
day, mice were tested twice at 3 to 30 rpm over 5 min
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Disease onset was retrospectively determined using the
age of peak body weight preceding denervation muscle
atrophy onset as previously described [22]. Onset of
motor deficit was determined using the age of peak
rotarod activity preceding first impairment. For survival
analysis, mice were killed by lethal injection at clinical
end point defined by onset of hindlimb paralysis.
Histology
Mice were transcardially perfused with PBS followed by
4% paraformaldehyde (PFA) in 0.1 M phosphate buffer.
Lumbar spinal cords were dissected out, postfixed in 4%
PFA for 2 h and cryoprotected in 30% sucrose in PBS
overnight at 4°C. Cords were embedded in optimal cut-
ting temperature medium by freezing in isopentane
cooled by liquid nitrogen. Horizontal 20-μm sections
were serially cut and stained with 0.5% cresyl violet
using a standard protocol, dehydrated and coverslipped.
Nissl-positive motor neurons in every third section were
counted from a total of 60 ventral horns per mouse (n =
3 to 4 mice per group) identified by neuronal morph-
ology and size exceeding 20-μm diameter with a distinct
nucleolar profile.
Immunohistochemistry
Spinal cord sections were permeabilised in 0.4% TX-
100 in PBS for 10 min; blocked in 5% skim milk in PBS
for 30 min and incubated with mouse NeuN (1:1,000,
Millipore, MAB377, Bayswater, VIC, Australia), mouse
glial fibrillary acidic protein (GFAP) (1:200, Millipore,
MAB360), mouse CD11b (1:100, MCA275GA, Serotec,
Raleigh, NC, USA) or rabbit AR (1:100, Millipore, 06–080)
antibodies overnight at 4°C. For M1 and M2 microglial
staining, sections were incubated with mouse iNOS (1:100,
sc-7271, Santa Cruz Biotechnology, TX, USA) or mouse
Arg1 (1:100, sc-271430, Santa Cruz Biotechnology,) and
goat Iba1 (1:200, ab107159, Abcam, Cambridge, UK).
Sections were incubated with Alexa Fluor-conjugated
secondary antibodies (1:200, Molecular Probes, Life
Technologies, Mulgrave, VIC, Australia) for 2 h, stained
with Hoechst 33342 (1:10,000, Invitrogen) for 15 min
and mounted using fluorescent mounting medium
(Dako, North Sydney, NSW, Australia) for microscopy
using an Olympus FV 1000 (Olympus, Notting Hill,
VIC, Australia) confocal microscope. Representative
images are shown from n = 3 to 4 mice per group. Im-
ages were captured using identical exposure and gain
settings. Negative controls without primary antibodies
were performed which produced no staining.
Immunoblotting
Fresh-frozen lumbar spinal cords were homogenised in
RIPA lysis buffer containing 50 mM Tris-Cl, pH 7.4,150 mM NaCl, 0.1% SDS, 1% sodium deoxycholate, 1%
TX-100 and 1% protease inhibitor cocktail (Sigma-
Aldrich, Castle Hill, NSW, Australia) by sonication at
50% output for 15 s; stored on ice for 20 min and centri-
fuged at 15,800 g for 20 min to collect supernatants.
Proteins (20 μg) were electrophoresed through 12.5%
SDS-polyacrylamide gels and transferred to Immobilon
PVDF-FL membranes (Millipore). Membranes were
blocked with 5% skim milk in TBST, pH 8.0, for 30 min
and incubated with sheep SOD1 (1:4,000, 574597,
Millipore), rabbit AR (1:500) or mouse β-actin (1:2,000,
Sigma, A5316) antibodies overnight at 4°C. Blots were
incubated with IRDye-conjugated secondary antibodies
(1:10,000, Li-Cor, Lincoln, NE, USA) and imaged using
the Odyssey Classic near infrared detection system.
Blots were quantified by taking the mean grey value of
SOD1 and AR bands normalised to β-actin level after
subtracting background intensity.
Fluorescence activated cell sorting analysis
Peripheral blood (approximately 200 μl) from mice (n =
4 per group) was collected at 2 weeks post-surgery and
analysed for B cell, T cell and total cell number using
density centrifugation and fluorescence activated cell
sorting (FACS). Blood samples stored on ice were pulsed
and resuspended in 1.5 ml mouse tonicity (MT)-PBS.
Samples were underlaid by 1.5 ml Histopaque 1077
(Sigma) and centrifuged at 2,000 rpm for 20 min to
allow separation of cells. The mononuclear layer was re-
covered and washed in MT-PBS and diluted four- to
fivefold. A 10-μl sample was added to an equal volume
of eosin and cells counted using a haemocytometer.
Cells were transferred to glass conical tubes and centri-
fuged at 1,700 rpm for 7 min and incubated with 20 μl
of an antibody cocktail of rat CD4-FITC (Molecular
Probes), CD8-APC (ProZyme, Hayward, CA, USA),
B220-Alexa 680 (ProZyme), GR-1-PeCy7 and M1-70-Pe
on ice for 25 min. Following incubation, 1 ml KDS-BSS
(balanced salt solution, 4-(2-hydroxyethyl)-1-piperazi-
neethanesulfonic acid (HEPES)-buffered MT buffer,
pH 7.22, containing 1.68 M NaCl, 1.68 M KCl, 1.12 M
CaCl2, 1.68 M MgSO4, potassium phosphate buffer, buff-
ered with 1.68 M HEPES made up in Milli-Q H2O,
osmolarity 308 to 310) with 3% FCS was added with
0.2 ml FCS underlay and cells washed. Cells were resus-
pended in 100 μl KDS-BSS with 3% FCS + propidium
iodide (0.1 μg/ml, Calbiochem) and analysed by LSR II
flow cytometer (BD Biosciences, North Ryde, NSW,
Australia) using 50,000 events. Splenocytes were used
for single colour compensation controls. Total T cell
number was determined using CD4 and CD8 marker ex-
pression which is restricted to T cells in mice, except for
conventional DCs which do not circulate in peripheral
blood and are selected against by lymphocyte gating.
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Data are expressed as mean ± standard error of the mean
(SEM). Blood cell counts, thymus weight, Western blot
densitometry, disease onset and rotarod deficit were ana-
lysed by unpaired t test. Neuronal counts were analysed
using one-way ANOVA. Survival data were analysed
using Kaplan-Meier survival analysis with the log-rank
test. Analyses were performed using GraphPad Prism 5.0
software (GraphPad, La Jolla, CA, USA).
Results
Castration blocks thymus atrophy and increases CD4+ T
cell number in mutant SOD1 mice
We tested the effects of thymic stimulation on the dis-
ease phenotype of male transgenic SOD1G93A mice using
surgical castration. Castrations were performed on 5-
week-old mice which is the time of peak thymus activityFigure 1 Castration stimulates thymus growth and CD4+ T cell produ
and castrated (Cx) SOD1G93A mice at 120 days. Data are mean ± SEM, n = 5
flow cytometric analysis of CD4+ and CD8+ T cells from the blood of mice de
analysis of blood cells at 2 weeks post-castration showing total T cell, CD4+ T
shown) for sham and Cx mice, n = 4. **P < 0.01 compared to sham group. (D
FoxP3+ T cells from blood of mice demonstrating the gates used and percen
(Treg) counts for sham and Cx mice, n = 4.preceding puberty. Castration resulted in a 50% increase
in thymus weight of mice compared to the sham group
(P < 0.05), confirming androgen deprivation (Figure 1A).
We next determined circulating T cell numbers in mice,
and representative FACS plots for CD4+ and CD8+ T
cells are shown (Figure 1B). Consistent with thymic
stimulation, the total T cell number was significantly in-
creased in the blood of castrated mice (P < 0.01, Figure 1C).
This resulted from a significant twofold increase in CD4+
T cell number (P < 0.01), while CD8+ T cell and B cell
numbers were not significantly affected by castration.
Thymic stimulation does not alter disease progression or
survival in mutant SOD1 mice
We next examined whether thymic stimulation of CD4+ T
cell production alters clinical disease onset, progression and
lifespan in male SOD1G93A mice. As shown in Figure 2A,ction in male SOD1G93A mice. (A) Wet weight of thymus of sham
, *P < 0.05 compared to sham group. (B) Representative scatter plot of
monstrating the gates used and percentage of positive cells. (C) FACS
cell, CD8+ T cell and B cell counts (monocytes and macrophages not
) Representative scatter plot of flow cytometric analysis of CD4+ and
tage of positive cells. (E) FACS analysis of blood CD4+ FoxP3+ T cell
Figure 2 Effect of thymic stimulation by castration on disease onset, progression and survival in male SOD1G93A mice. (A) Castrated (Cx)
mice showed a consistent reduction in body weight throughout life compared to the sham group, although not statistically significant. (B) Motor
performance of Cx and sham mice determined by weekly rotarod test was similar. (C) Survival of Cx and sham mice was similar. Data are mean ±
SEM, n = 10.
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than shams, as expected following androgen removal.
However, disease onset determined by the age of peak
body weight preceding muscle wasting was similar in
both groups (Cx 100 ± 5 days, sham 97 ± 5 days, mean
± SEM. The onset of locomotor dysfunction deter-
mined by the age of peak rotarod performance was alsoFigure 3 Effect of thymic stimulation by castration on motor neuron
photomicrographs of ventral horns of lumbar spinal cords of wild-type (WT
at 120 days. Scale bar = 100 μm. (B) Quantification of average spinal motor ne
n = 3 to 4.similar between groups (Cx 68 ± 8 days, sham 77 ±
4 days, Figure 2B). Lastly, survival, defined by age of
onset of hindlimb paralysis, was not significantly af-
fected by castration in mice (Cx 136 ± 2 days, sham
137 ± 3 days, Figure 2C). Hence, stimulation of thymic
activity and CD4+ T cell number does not change dis-
ease onset or progression in male SOD1G93A mice.loss in spinal cords of male SOD1G93A mice. (A) Representative
) or sham and castrated (Cx) SOD1G93A mice stained with cresyl violet
uron number per ventral horn from (A) is shown. Data are mean ± SEM,
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by castration did not improve the disease phenotype of
mice as we hypothesised, we counted Treg numbers. A
representative FACS plot for CD4+ FoxP3+ T cells is
shown (Figure 1D). Despite boosting CD4+ T cell number
overall, FoxP3+ Treg levels were not significantly changed
by castration (Figure 1E).Thymic stimulation does not affect spinal motor neuron loss,
but reduces microglial activation in mutant SOD1 mice
To determine whether thymic stimulation affects spinal
cord pathology, we quantified spinal motor neuron num-
bers in castrated and sham mice at P120 (Figure 3A, B).
In sham SOD1G93A mice, there was an approximately
50% loss of motor neurons compared to age-matched
WT mice. Castration did not affect the severity of motor
neuron loss in SOD1G93A mice.Figure 4 Effect of thymic stimulation by castration on glial cell activa
analysis of lumbar spinal cords of wild-type (WT) or sham and castrated (Cx
activation identified by GFAP is increased in sham SOD1G93A mice, but not aff
sham SOD1G93A mice and reduced by castration. Scale bar = 30 μm. RepresenAstrocyte activation was next assessed using the
marker GFAP. In sham SOD1G93A mice, there was a
pronounced astrocyte activation relative to WT mice in
the spinal cord (Figure 4A). Astrocyte activation was
similar in castrated and sham SOD1G93A mice. Micro-
glial activation measured using the marker CD11b was
increased in sham SOD1G93A mice compared to WT ani-
mals (Figure 4B). However, microglial activation was
markedly reduced by castration in SOD1G93A mice, con-
sistent with the mitigating effects of increased CD4+ T
cells overall on the microglia phenotype.
To further characterise the phenotype of microglia, we
used iNOS and Arg1 as markers of M1 and M2 micro-
glia as previously described in mutant SOD1 mice [23].
iNOS-positive microglia were identified in spinal cords
of sham SOD1G93A mice and were clearly reduced by
castration (Figure 5A), suggesting attenuated M1 micro-
glial activation. Conversely, Arg1-positive microgliation in spinal cords of male SOD1G93A mice. Immunohistochemical
) SOD1G93A mice at 120 days for (A) GFAP and (B) CD11b. Astrocytic
ected by castration. Microglial activation shown by CD11b is increased in
tative photomicrographs from two mice per group are shown.
Figure 5 Effect of thymic stimulation by castration on M1 and
M2 microglial activation in spinal cords of male SOD1G93A mice.
Immunohistochemical analysis of lumbar spinal cords of sham and
castrated (Cx) SOD1G93A mice at 120 days for (A) iNOS and (B) Arg1.
M1 microglial activation shown by iNOS in sham SOD1G93A mice is
reduced by castration. M2 microglial activation shown by Arg1 in
sham SOD1G93A mice is increased by castration. Microglia were
identified by Iba1 (not shown). Scale bar = 20 μm. Representative
photomicrographs from two mice per group are shown.
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SOD1G93A mice, compared to the sham group (Figure 5B).
This implies that castration may affect the phenotype of
microglia, promoting less pro-inflammatory microglia in
spinal cords of mutant SOD1 mice.Castration and mutant SOD1 reduce androgen receptor
expression in spinal motor neurons
We next assessed AR expression level and cellular local-
isation in spinal cords of SOD1G93A mice in response to
castration. AR expression level was first measured inspinal cords of intact WT and SOD1G93A mice at pre-
symptomatic P60, disease onset P90 and symptomatic
P120 time points. An approximately 100-kDa band cor-
responding to AR was detected in spinal cords of mice
by Western blot analysis (Figure 5A). AR protein levels
were similar in mice at P60 (Figure 6A, B). AR expression
was reduced by 12% at P90 and 33% at P120 (P < 0.01),
suggesting that mutant SOD1 leads to progressive down-
regulation of AR from disease onset. Castration re-
sulted in a significant further 50% depletion of AR
protein in SOD1G93A mice compared to shams (P < 0.01,
Figure 6C, D), reflecting androgen deprivation. Castration
did not affect mutant SOD1 transgene expression level in
spinal cords of mice (Figure 6C).
The cellular distribution of AR was next studied in
spinal cord sections. In WT mice, AR was highly expressed
in motor neuron cell bodies identified by size, ventral horn
location and NeuN immunoreactivity (Figure 7). AR ex-
pression was reduced in motor neuron cell bodies of sham
SOD1G93A mice and appeared redistributed to axons and/
or dendrites. Castration of SOD1G93A mice further re-
duced AR expression on somas of motor neurons, in line
with our Western blot results (Figure 6).
To address whether AR is expressed by glial cells in
healthy or SOD1G93A mice, we studied its localisation
using GFAP or CD11b double immunofluorescence in
the spinal cord. In WT mice, AR was not detected in as-
trocytes, but clearly expressed in neighbouring motor
neurons (Figure 8A). In sham SOD1G93A mice, activated
astrocytes did not express AR and this was not affected
by castration. Furthermore, in WT mice, AR was not de-
tected in microglia, but again was abundant in adjacent
motor neurons (Figure 8B). Activated microglia did not
express AR in sham or castrated SOD1G93A mice. Thus,
AR is predominantly expressed by motor neurons in the
spinal cord, consistent with selective neuronal vulner-
ability in SBMA, while both mutant SOD1 action and
castration lead to its depletion, reminiscent of SBMA.
Discussion
Previous studies have implicated adaptive immune sys-
tem dysfunction in ALS patients and mutant SOD1
mice, showing accelerated thymus inactivation or involu-
tion, reduced CD4+ T cell number, spleen shrinkage and
lymphopenia [15,16,20,21]. Whether thymus dysfunction
and related deficiency of mature T cells are responsible
or reactive in neurodegeneration in ALS remains unclear
from these studies. To determine whether increased
thymic activity and T cell production can modulate the
disease phenotype of mutant SOD1 mice, we stimulated
thymic function in presymptomatic SOD1G93A mice
using castration. Chemical or surgical castration is well
proven to promote thymic function by depriving circu-
lating androgens that mediate age-dependent atrophy of
Figure 6 Castration and mutant SOD1 expression reduces androgen receptor protein level in spinal cords of SOD1G93A mice. (A)
Western blot analysis of AR expression levels in lumbar spinal cords of wild-type (WT) and SOD1G93A mice at 60, 90 and 120 days. (B) Quantification of
AR expression from (A) is shown. Data are mean ± SEM normalised to β-actin and expressed as percentage of WT mice. n = 4, *P < 0.05 compared to
WT mice. (C) Western blot analysis of AR and SOD1 expression in lumbar spinal cords of sham and castrated (Cx) SOD1G93A mice at 120 days. (D)
Quantification of AR expression from (C) is shown. Data are mean ± SEM normalised to β-actin and expressed as percentage of sham mice. n = 4 to 5,
**P < 0.01 compared to sham group.
Figure 7 Androgen receptor expression is reduced in spinal motor neurons by mutant SOD1 action and castration in mice.
Immunohistochemical analysis of lumbar spinal cords of wild-type (WT) or sham and castrated (Cx) SOD1G93A mice at 120 days for androgen receptor
(AR) and motor neurons (NeuN). AR is mainly localised within the cytoplasm of motor neuron cell bodies in WT mice. AR expression is reduced in
motor neurons of SOD1G93A mice and redistributed to axons and/or dendrites and further depleted in Cx SOD1G93A mice. Scale bar = 30 μm.
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Figure 8 Androgen receptor is mainly expressed by motor neurons in spinal cords of normal or mutant SOD1 mice. Immunohistochemical
analysis of lumbar spinal cords of wild-type (WT) or sham and castrated (Cx) SOD1G93A mice at 120 days for androgen receptor (AR) and (A) GFAP or
(B) CD11b. AR is mainly localised to motor neurons evident by cell size and location, but not astrocytes or microglia in WT or sham and Cx SOD1G93A
mice. Scale bar = 30 μm.
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can remarkably rejuvenate the thymus in pubescent or
aged mice, leading to sustained production of mature T
cells throughout life [24]. We chose to castrate male
SOD1G93A mice at 5 weeks which precedes both puberty
and clinical symptoms to maximise the effects of thymic
stimulation of mature T cell production on disease. Cas-
tration significantly opposed thymus atrophy induced by
androgens and disease progression in our study. This is
consistent with another report showing increased thy-
mus growth as early as 2 weeks post-castration in WT
mice [25]. We also demonstrated a doubling of CD4+ T
cell number at 2 weeks post-castration, concordant with
other reports in mice [6,25]. Interestingly, we potenti-
ated CD4+ T cell output, but not of CD8+ T cells, by
castration in SOD1G93A mice. CD4+ T cells are recruited
early and linked to protection of neurons in models ofaxotomy [26], Parkinson’s disease [27] and ALS [28],
while CD8+ T cells are present in affected tissue in end-
stage disease in ALS and respond mainly to injury [28].
Despite boosting total CD4+ T cell number, thymic
stimulation of SOD1G93A mice did not delay disease on-
set or extend lifespan in our study. This contrasts with
other reports using passive transfer of CD4+ T cells or
Tregs to genetically T cell-deficient and bone marrow-
ablated SOD1G93A mice which significantly prolonged
lifespan [15,16]. Various discrepancies may account for
differences in results observed between our studies,
namely the high purity, dose (up to 2 × 108 cells repeat-
edly injected) and ex vivo activation of T cells in some of
these studies, in contrast to our induction of natural
thymic T cell production by castration. Another differ-
ence to these passive transfer experiments was the abla-
tion of endogenous T cells expressing mutant SOD1 and
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[15,16], whereas our study induced mutant SOD1 ex-
pressing T cells on an intact adaptive immune system
background. Another possibility is that castration-
induced effects on the thymus may be transient, leading
to increased thymus size and CD4+ T cell production
that could eventually decline with age [29], although the
increased weight of the thymus at end stage in SOD1G93A
mice argues against this.
One key difference from our study is that castration
was unable to promote expansion of Tregs, which are
linked to neuroprotection in ALS. Tregs which comprise
5% to 10% of peripheral CD4+ T cells [30] may be essen-
tial for slowing disease progression in mutant SOD1
mice. However, our findings are consistent with other
studies showing that physical or chemical castration re-
sults in increased thymic output that is predominantly
in the form of naive T cells [6,24,25]. Another possible
explanation for the inability of castration to expand Treg
number may result from the different homeostatic
mechanisms between naive CD4+ T cells and Tregs.
Tregs constitutively express the interleukin 2 receptor
(IL-2R) and are more responsive and dependent on IL-2
than naive T cells which lack the alpha chain of IL-2R
(CD25) [31]. While castration increases thymic output,
homeostatic control of T cell numbers is not uniform
and Treg numbers are limited by IL-2 availability, unlike
naive cells. Disease progression in mutant SOD1 mice
likely further decouples Tregs from total T cell numbers,
as there is evidence that Treg numbers are reduced in
ALS patients [21].
Interestingly, we observed a marked reduction in
microglial activation, specifically M1 microglia, in spinal
cords of castrated SOD1G93A mice which would imply
an attenuation of neuroinflammation independently of
Tregs. Thus, other CD4+ T cell subtypes may also
modulate microglial activation in ALS models. Surpris-
ingly, the marked reduction in microgliosis did not con-
fer any benefit to clinical progression and motor neuron
survival in mutant SOD1 mice. This contrasts with pre-
vious studies showing delayed disease progression in
mutant SOD1 mice with suppression of M1 microglial
activation or phenotype [16]. While this discrepancy
most likely reflects the different approaches used to
modulate microglial activation and degree of modulation,
our results suggest that inhibition of microglial activation
as a treatment goal may not be as straightforward in this
mouse model of ALS.
Our evidence showing no effect of castration on disease
onset and progression in SOD1G93A mice is consistent
with a recent report using SOD1G93A rats [32]. Gonadec-
tomy of presymptomatic male or female SOD1G93A rats
did not affect disease onset or survival, nor did treatment
with the steroid dehydroepiandrosterone [32]. In contrast,treatment of castrated male SOD1G93A mice with an ana-
bolic steroid, nandrolone decanoate, worsened clinical
outcome, although castration alone did not significantly
modify survival [33]. Furthermore, administration of di-
hydrotestosterone to male SOD1G93A mice promoted
muscle growth and strength and led to modest improve-
ments in motor function and lifespan [34]. Despite this,
ovariectomy of SOD1G93A mice hastened disease progres-
sion which was rescued by 17β-estradiol therapy [35].
Hence, androgen deprivation induced by castration in
male SOD1G93A rats [32] and mice here does not affect
disease course, suggesting that factors other than circulat-
ing androgens may account for the increased incidence of
ALS in males than females in humans [36] and reduced
survival of male SOD1G93A mice compared to females [37].
However, androgen and oestrogen therapy in SOD1G93A
mice is protective, possibly by stimulating muscle growth
and strength, independent of motor neuron survival.
Interestingly, castration of male TDP-43A315T mice did
not significantly impact on survival [38], arguing against
an androgen-dependent disease phenotype in these mice.
One potentially important finding from our study was
that AR expression in spinal motor neurons was reduced
by mutant SOD1 action and castration in mice. AR ex-
pression was previously described in motor neurons [39];
however, we show that AR is predominantly expressed by
spinal motor neurons, but not astrocytes and microglia.
Downregulation of AR in the gonads occurs in response
to circulating androgen depletion by castration [40], con-
sistent with our findings in the spinal cord. Our discovery
of progressive AR depletion in spinal cords in SOD1G93A
mice from disease onset is a novel finding. While this
could reflect motor neuron loss, reduced expression of
AR on spinal motor neurons suggests a potential patho-
logical role in neurodegeneration in these mice. Patho-
genic expansions in AR leading to its inactivation causes
lower motor neuron loss and muscle wasting in spinal
bulbar muscular atrophy (SBMA) or Kennedy’s disease
[41]. Pathogenic-expanded AR is linked to neurodegen-
eration by loss of normal AR trophic signalling, leading
to transcriptional dysregulation of growth factors re-
quired for motor neuron survival such as brain-derived
neurotrophic factor and transforming growth factor-β
[42,43]. In addition, nuclear accumulation of toxic AR-
polyglutamine expansions in motor neurons is impli-
cated in SBMA [44]. It is noteworthy that we did not
observe nuclear inclusions of AR in motor neurons of
mutant SOD1 mice, implying a loss-of-function of AR
in ALS. We therefore propose that AR reduction in
spinal motor neurons may contribute to selective neur-
onal susceptibility in ALS. If supported, then ALS and
SBMA could share a common disease pathway mediated
by disruption of AR expression and function in spinal
motor neurons.
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In conclusion, we demonstrate that stimulation of thymic
function and CD4+ T cell production in mutant SOD1
mice does not delay disease onset and progression, in con-
trast to studies using passive transfer of Tregs. This may
result from an inability of thymic activation induced by
castration to increase neuroprotective Treg number due
to limited IL-2 availability. Despite this, M1 microglia acti-
vation was reduced by this approach, although not confer-
ring clinical benefit. Interestingly, we have discovered that
AR is depleted in spinal motor neurons during the disease
course of mutant SOD1 mice, suggesting a potential con-
vergence of pathogenic mechanisms in ALS and SBMA
that warrants further investigation.
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